Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos de Cheplapharm Arzneimittel Gmbh en Spain

M
MASTICAL D LEMON FLAVORED 500 mg/400 IU CHEWABLE TABLETS
Dosage form:  CHEWABLE TABLET, 500 mg, Calcium / 10 mcg, Cholecalciferol
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MASTICAL D UNIDIA 1000 MG/800 IU CHEWABLE TABLETS
Dosage form:  CHEWABLE TABLET, Calcium Carbonate/ Cholecalciferol
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MASTICAL D 500 mg / 400 IU CHEWABLE TABLETS ORANGE FLAVOR
Dosage form:  CHEWABLE TABLET, 500 mg calcium carbonate; 400 IU cholecalciferol
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MASTICAL D 500 MG/1000 IU CHEWABLE TABLETS STRAWBERRY FLAVOR
Dosage form:  CHEWABLE TABLET, 500 mg / 1000 IU (25 mcg)
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MASTICAL D 500 MG/400 IU CHEWABLE TABLETS STRAWBERRY FLAVOR
Dosage form:  CHEWABLE TABLET, 500 mg / 400 IU (10 mcg)
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MASTICAL D 500 MG/800 IU CHEWABLE TABLETS
Dosage form:  CHEWABLE TABLET, 500 mg (1250 mg) 20 mcg
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MASTICAL 500 mg CHEWABLE TABLETS
Dosage form:  CHEWABLE TABLET, 500 mg
Active substance:  calcium carbonate
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription not required
MOLSIDAIN 2 mg TABLETS
Dosage form:  TABLET, 2 mg
Active substance:  molsidomine
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MOLSIDAIN 4 mg TABLETS
Dosage form:  TABLET, 4 mg
Active substance:  molsidomine
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
MYOCET LIPOSOMAL 50 MG POWDER, DISPERSION AND SOLVENT FOR CONCENTRATE FOR DISPERSION FOR INFUSION
Dosage form:  INJECTABLE INFUSION, Unknown
Active substance:  doxorubicin
Manufacturer:  Cheplapharm Arzneimittel Gmbh
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media